116 related articles for article (PubMed ID: 3570555)
1. Evidence for a warfarin-sensitive serum factor that participates in factor X activation by Lewis lung tumor cells.
Fasco MJ; Wilson AC; Lincoln D; Gierthy J
Int J Cancer; 1987 May; 39(5):631-7. PubMed ID: 3570555
[TBL] [Abstract][Full Text] [Related]
2. Loss of metastatic and primary tumor factor X activator capabilities by Lewis lung carcinoma cells cultured in vitamin K-dependent protein deficient serum.
Fasco MJ; Eagan GE; Wilson AC; Gierthy JF; Lincoln DL
Cancer Res; 1988 Nov; 48(22):6504-9. PubMed ID: 3180067
[TBL] [Abstract][Full Text] [Related]
3. Cancer cell procoagulant: a novel vitamin K-dependent activity.
Delaini F; Colucci M; De Bellis Vitti G; Locati D; Poggi A; Semeraro N; Donati MB
Thromb Res; 1981 Nov; 24(3):263-6. PubMed ID: 7336382
[No Abstract] [Full Text] [Related]
4. Warfarin inhibits both procoagulant activity and metastatic capacity of Lewis lung carcinoma cells. Role of vitamin K deficiency.
Colucci M; Delaini F; de Bellis Vitti G; Locati D; Poggi A; Semeraro N; Donati MB
Biochem Pharmacol; 1983 Jun; 32(11):1689-91. PubMed ID: 6870908
[TBL] [Abstract][Full Text] [Related]
5. Vitamin-K-dependent proteins in microsomes of primary Lewis lung tumors.
Wilson AC; Fasco MJ
Int J Cancer; 1986 Dec; 38(6):877-82. PubMed ID: 3793264
[TBL] [Abstract][Full Text] [Related]
6. Vitamin K-dependent procoagulant in cancer cells: a potential target for the antimetastatic effect of warfarin?
Donati MB; Roncaglioni MC; Falanga A; Casali B; Semeraro N
Haemostasis; 1986; 16(3-4):288-94. PubMed ID: 3530903
[TBL] [Abstract][Full Text] [Related]
7. Increased susceptibility to the anticoagulant effect of warfarin in mice bearing the Lewis lung carcinoma. Role of vitamin K deficiency.
Pezzi L; Gerna M; Roncaglioni MC; Vermeer C; Donati MB
Biochem Pharmacol; 1986 Oct; 35(19):3239-42. PubMed ID: 3768019
[TBL] [Abstract][Full Text] [Related]
8. The endotoxin-induced procoagulant of mouse exudate macrophages: a factor-X activator.
Shands JW
Blood; 1983 Aug; 62(2):333-40. PubMed ID: 6871467
[TBL] [Abstract][Full Text] [Related]
9. Mechanism of the anticoagulant effect of warfarin as evaluated in rabbits by selective depression of individual procoagulant vitamin K-dependent clotting factors.
Zivelin A; Rao LV; Rapaport SI
J Clin Invest; 1993 Nov; 92(5):2131-40. PubMed ID: 8227329
[TBL] [Abstract][Full Text] [Related]
10. Effects of vitamin K deficiency, warfarin, and inhibitors of protein synthesis upon the plasma levels of vitamin K-dependent clotting factors in the chick.
Walz DA; Kipfer RK; Olson RE
J Nutr; 1975 Aug; 105(8):972-81. PubMed ID: 1142015
[TBL] [Abstract][Full Text] [Related]
11. gamma-Glutamyl carboxylase activity in experimental tumor tissues: a biochemical basis for vitamin K dependence of cancer procoagulant.
Roncaglioni MC; Dalessandro AP; Casali B; Vermeer C; Donati MB
Haemostasis; 1986; 16(3-4):295-9. PubMed ID: 3530904
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of warfarin in the nephrotic syndrome and effect on vitamin K-dependent clotting factors.
Ganeval D; Fischer AM; Barre J; Pertuiset N; Dautzenberg MD; Jungers P; Houin G
Clin Nephrol; 1986 Feb; 25(2):75-80. PubMed ID: 3698349
[TBL] [Abstract][Full Text] [Related]
13. Failure to warfarin to affect the tissue factor activity and the metastatic potential of murine fibrosarcoma cells.
Lorenzet R; Bottazzi B; Locati D; Colucci M; Mantovani A; Semeraro N; Donati MB
Eur J Cancer Clin Oncol; 1985 Feb; 21(2):263-5. PubMed ID: 3987761
[TBL] [Abstract][Full Text] [Related]
14. Reduced procoagulant activity of Lewis lung carcinoma cells from mice treated with warfarin.
Poggi A; Colucci M; Delaini F; Semeraro N; Donati MB
Eur J Cancer (1965); 1980 Dec; 16(12):1641-2. PubMed ID: 7227438
[No Abstract] [Full Text] [Related]
15. The vitamin K-dependent carboxylation system in human osteosarcoma U2-OS cells. Antidotal effect of vitamin K1 and a novel mechanism for the action of warfarin.
Wallin R; Rossi F; Loeser R; Key LL
Biochem J; 1990 Jul; 269(2):459-64. PubMed ID: 2386486
[TBL] [Abstract][Full Text] [Related]
16. Multiple vitamin K-dependent coagulation zymogens promote adenovirus-mediated gene delivery to hepatocytes.
Parker AL; Waddington SN; Nicol CG; Shayakhmetov DM; Buckley SM; Denby L; Kemball-Cook G; Ni S; Lieber A; McVey JH; Nicklin SA; Baker AH
Blood; 2006 Oct; 108(8):2554-61. PubMed ID: 16788098
[TBL] [Abstract][Full Text] [Related]
17. Poor correlation of supratherapeutic international normalised ratio and vitamin K-dependent procoagulant factor levels during warfarin therapy.
Sarode R; Rawal A; Lee R; Shen YM; Frenkel EP
Br J Haematol; 2006 Mar; 132(5):604-7. PubMed ID: 16445834
[TBL] [Abstract][Full Text] [Related]
18. VKORC1: a warfarin-sensitive enzyme in vitamin K metabolism and biosynthesis of vitamin K-dependent blood coagulation factors.
Wallin R; Wajih N; Hutson SM
Vitam Horm; 2008; 78():227-46. PubMed ID: 18374197
[TBL] [Abstract][Full Text] [Related]
19. Unique secretion mode of human protein Z: its Gla domain is responsible for inefficient, vitamin K-dependent and warfarin-sensitive secretion.
Souri M; Iwata H; Zhang WG; Ichinose A
Blood; 2009 Apr; 113(16):3857-64. PubMed ID: 19188667
[TBL] [Abstract][Full Text] [Related]
20. The effect of Warfarin and factor VII on tissue procoagulant activity and pulmonary seeding.
Francis JL; Carty N; Amirkhosravi M; Loizidou M; Cooper A; Taylor I
Br J Cancer; 1992 Mar; 65(3):329-34. PubMed ID: 1558784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
